We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Receives FDA Approval for Gabapentin Tablets
Ranbaxy Receives FDA Approval for Gabapentin Tablets
September 20, 2005
Ranbaxy Laboratories has received FDA approval to manufacture and market a generic version of Pfizer’s Neurontin (gabapentin) in 600- and 800-mg tablets.